Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001628280-24-048162)

Filing Details

Accession Number:: 0001628280-24-048162
Form Type:: 5
Zero Holdings:: No
Publication Time:: 2024-11-15 20:34:11
Reporting Period:: 2024-09-30

Accepted Time:: 2024-11-15 20:34:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879407	Arrowhead Pharmaceuticals Inc.	ARWR	Pharmaceutical Preparations (2834)	460408024

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1767584	Hongbo Lu	177 E. Colorado Blvd Suite 700 Pasadena CA 91105		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-03-22	400	$28.00	34,080	No	4	P	Direct
Common Stock	Acquisiton	2024-03-26	850	$27.50	34,930	No	4	P	Direct
Common Stock	Acquisiton	2024-04-02	150	$27.34	35,080	No	4	P	Direct
Common Stock	Acquisiton	2024-04-10	500	$25.00	35,580	No	4	P	Direct
Common Stock	Acquisiton	2024-04-18	500	$22.00	36,080	No	4	P	Direct
Common Stock	Disposition	2024-09-25	5,650	$0.00	30,430	No	4	G	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	G	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,650	Indirect	By spouse

Footnotes

Includes previously reported restricted stock units, which are subject to certain vesting conditions.
On September 25, 2024, the Reporting Person transferred 5,650 shares of the Issuer's common stock from a jointly-held retirement account to her spouse's individual retirement account for no consideration.